THE POLITICS OF MEDICINE
The infectious-disease specialist who briefed President Trump last month on the safety and effectiveness of hydroxychloroquine will no longer be allowed to prescribe the drug to patients at the New York City-area hospital where he has admitting privileges unless it's done in a clinical trial.
The infectious-disease specialist who briefed President Trump last month on the safety and effectiveness of hydroxychloroquine will no longer be allowed to prescribe the drug to patients at the New York City-area hospital where he has admitting privileges unless it's done in a clinical trial.

No comments:
Post a Comment